ID | Drug Name | Action | PubMed |
---|---|---|---|
C031903 | 1-UFT protocol | MRE11 protein results in decreased susceptibility to 1-UFT protocol | 16734730 |
C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA" | 19167446 |
C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in decreased expression of MRE11 protein | 26194647 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of MRE11 mRNA | 22230336 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of MRE11 gene | 27153756 |
C016274 | bromoacetate | bromoacetate results in increased expression of MRE11 mRNA | 19753638 |
D002166 | Camptothecin | Camptothecin results in decreased expression of MRE11 mRNA | 24792648 |
D000069287 | Capecitabine | MRE11 protein results in decreased susceptibility to Capecitabine | 16734730 |
C099555 | CD 437 | CD 437 results in decreased expression of MRE11 protein | 15059897 |
C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of MRE11 protein | 25173789 |
D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in increased expression of MRE11 protein | 20931265 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of MRE11 mRNA | 19549813 |
D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA" | 19167446 |
D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of MRE11 mRNA | 19167446 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of MRE11 mRNA | 20106945 |
C089595 | cylindrospermopsin | cylindrospermopsin results in decreased expression of MRE11 mRNA | 23726867 |
C014347 | decitabine | decitabine affects the localization of MRE11 protein modified form | 17991895 |
D002945 | Cisplatin | Cisplatin results in increased expression of MRE11 protein | 26723870 |
D004126 | Dimethylformamide | Dimethylformamide results in increased expression of MRE11 mRNA | 26387567 |
D004126 | Dimethylformamide | Dimethylformamide results in increased expression of MRE11 protein | 26387567 |
C025034 | doxifluridine | MRE11 protein results in decreased susceptibility to doxifluridine | 16734730 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MRE11 mRNA | 22079256 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of MRE11 mRNA | 20044591 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MRE11 mRNA | 25613284 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of MRE11 mRNA | 23649840 |
C005246 | myristicin | myristicin results in decreased expression of MRE11 mRNA | 24792648 |
D010419 | Pentamidine | Pentamidine results in decreased activity of MRE11 protein | 20144237 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of MRE11 mRNA | 23557933 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MRE11 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of MRE11 mRNA | 22079256 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of MRE11 mRNA | 23628323 |
D011794 | Quercetin | Quercetin results in decreased expression of MRE11 mRNA | 21632981 |
C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of MRE11 mRNA | 19167446 |
C059514 | resveratrol | resveratrol results in decreased expression of MRE11 protein | 22644231 |
C059514 | resveratrol | resveratrol results in decreased expression of [MRE11 protein binds to NBN protein binds to RAD50 protein] | 22644231 |
C547185 | riccardin D | riccardin D results in decreased expression of MRE11 mRNA | 24069304 |
D012402 | Rotenone | Rotenone results in increased expression of MRE11 mRNA | 18191903 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MRE11 mRNA | 25613284 |
D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in increased expression of MRE11 protein | 20931265 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of MRE11 mRNA | 23179753|2718838 |
C521013 | veliparib | MRE11 protein results in decreased susceptibility to veliparib | 21300766 |
D015032 | Zinc | Zinc deficiency results in decreased expression of MRE11 mRNA | 18356318 |
C023616 | zinc chromate | zinc chromate affects the expression of MRE11 protein | 25173789 |
C023616 | zinc chromate | zinc chromate results in increased expression of MRE11 protein | 19027772 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000014 | single-stranded DNA endodeoxyribonuclease activity | - | IBA | 21873635 |
GO:0000014 | single-stranded DNA endodeoxyribonuclease activity | - | IDA | 9705271 |
GO:0003677 | DNA binding | contributes_to | IDA | 15790808 |
GO:0003690 | double-stranded DNA binding | - | TAS | 10802669 |
GO:0003691 | double-stranded telomeric DNA binding | - | IBA | 21873635 |
GO:0004003 | ATP-dependent DNA helicase activity | contributes_to | IMP | 15790808 |
GO:0004518 | nuclease activity | - | TAS | 15790808 |
GO:0004519 | endonuclease activity | - | IBA | 21873635 |
GO:0004520 | endodeoxyribonuclease activity | - | IDA | 9705271 |
GO:0004520 | endodeoxyribonuclease activity | - | TAS | - |
GO:0005515 | protein binding | - | IPI | 12419185 15916964 16377563 17428914 17500065 17500595 17612497 18583988 18716619 19197236 19234442 19609304 21052091 22078559 22157895 24529708 24534091 24651726 25558984 25772236 26807646 27568553 |
GO:0008022 | protein C-terminus binding | - | IPI | 9590181 |
GO:0008408 | 3'-5' exonuclease activity | - | IBA | 21873635 |
GO:0008408 | 3'-5' exonuclease activity | - | IDA | 9651580 9705271 |
GO:0030145 | manganese ion binding | - | IBA | 21873635 |
GO:0030145 | manganese ion binding | - | IEA | - |
GO:0042802 | identical protein binding | - | IPI | 22078559 |
GO:0043047 | single-stranded telomeric DNA binding | - | IBA | 21873635 |
GO:0045296 | cadherin binding | - | HDA | 25468996 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000019 | regulation of mitotic recombination | - | TAS | 8530104 |
GO:0000723 | telomere maintenance | - | IBA | 21873635 |
GO:0000724 | double-strand break repair via homologous recombination | - | TAS | - |
GO:0000729 | DNA double-strand break processing | - | TAS | - |
GO:0006260 | DNA replication | - | TAS | - |
GO:0006281 | DNA repair | - | TAS | 9705271 9931460 |
GO:0006284 | base-excision repair | - | IBA | 21873635 |
GO:0006302 | double-strand break repair | - | IBA | 21873635 |
GO:0006302 | double-strand break repair | - | TAS | 10612394 |
GO:0006303 | double-strand break repair via nonhomologous end joining | - | IDA | 9651580 |
GO:0006303 | double-strand break repair via nonhomologous end joining | - | TAS | - |
GO:0006310 | DNA recombination | - | TAS | 9705271 |
GO:0006974 | cellular response to DNA damage stimulus | - | IDA | 17500065 |
GO:0007004 | telomere maintenance via telomerase | - | TAS | 9705271 9931460 |
GO:0007062 | sister chromatid cohesion | - | IBA | 21873635 |
GO:0007062 | sister chromatid cohesion | - | IMP | 15917200 |
GO:0007095 | mitotic G2 DNA damage checkpoint | - | IBA | 21873635 |
GO:0007095 | mitotic G2 DNA damage checkpoint | - | IEA | - |
GO:0007129 | synapsis | - | IEA | - |
GO:0007131 | reciprocal meiotic recombination | - | TAS | 8530104 9931460 |
GO:0008283 | cell proliferation | - | IEA | - |
GO:0016032 | viral process | - | IEA | - |
GO:0031573 | intra-S DNA damage checkpoint | - | IBA | 21873635 |
GO:0031860 | telomeric 3' overhang formation | - | IBA | 21873635 |
GO:0031860 | telomeric 3' overhang formation | - | IMP | 16374507 |
GO:0031954 | positive regulation of protein autophosphorylation | - | IDA | 15790808 |
GO:0032206 | positive regulation of telomere maintenance | - | IMP | 16374507 |
GO:0032481 | positive regulation of type I interferon production | - | TAS | - |
GO:0032508 | DNA duplex unwinding | - | IMP | 15790808 |
GO:0032876 | negative regulation of DNA endoreduplication | - | IMP | 15917200 |
GO:0033674 | positive regulation of kinase activity | - | IDA | 15790808 |
GO:0042138 | meiotic DNA double-strand break formation | - | IBA | 21873635 |
GO:0043066 | negative regulation of apoptotic process | - | IMP | 16374507 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | - | IEA | - |
GO:0097552 | mitochondrial double-strand break repair via homologous recombination | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000781 | chromosome, telomeric region | colocalizes_with | IDA | 15149599 |
GO:0000784 | nuclear chromosome, telomeric region | - | HDA | 19135898 |
GO:0000784 | nuclear chromosome, telomeric region | COLOCALIZES_WITH | IBA | 21873635 |
GO:0000784 | nuclear chromosome, telomeric region | - | IDA | 10811102 |
GO:0000784 | nuclear chromosome, telomeric region | colocalizes_with | IDA | 24270157 |
GO:0000784 | nuclear chromosome, telomeric region | colocalizes_with | ISS | - |
GO:0000785 | chromatin | - | IBA | 21873635 |
GO:0005634 | nucleus | - | TAS | 10802669 |
GO:0005654 | nucleoplasm | - | IDA | - |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005737 | cytoplasm | - | IDA | 25468996 |
GO:0005829 | cytosol | - | TAS | - |
GO:0016605 | PML body | - | IDA | 10811102 |
GO:0016605 | PML body | - | ISS | - |
GO:0030870 | Mre11 complex | - | IBA | 21873635 |
GO:0030870 | Mre11 complex | - | IDA | 19151086 |
GO:0030870 | Mre11 complex | - | NAS | 15790808 |
GO:0030870 | Mre11 complex | - | TAS | 27918544 |
GO:0035861 | site of double-strand break | - | IBA | 21873635 |
GO:0035861 | site of double-strand break | - | IDA | 15916964 |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1474165 | Reproduction | IEA |
R-HSA-1500620 | Meiosis | IEA |
R-HSA-1640170 | Cell Cycle | IEA |
R-HSA-1640170 | Cell Cycle | TAS |
R-HSA-168249 | Innate Immune System | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-1834941 | STING mediated induction of host immune responses | TAS |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | TAS |
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-2262752 | Cellular responses to stress | TAS |
R-HSA-2559583 | Cellular Senescence | TAS |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | TAS |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | TAS |
R-HSA-3700989 | Transcriptional Regulation by TP53 | TAS |
R-HSA-5633007 | Regulation of TP53 Activity | TAS |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | TAS |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | TAS |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | TAS |
R-HSA-5693532 | DNA Double-Strand Break Repair | TAS |
R-HSA-5693537 | Resolution of D-Loop Structures | TAS |
R-HSA-5693538 | Homology Directed Repair | TAS |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | TAS |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | TAS |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | TAS |
R-HSA-5693567 | HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) | TAS |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | TAS |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | TAS |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | TAS |
R-HSA-5693606 | DNA Double Strand Break Response | TAS |
R-HSA-5693607 | Processing of DNA double-strand break ends | TAS |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | TAS |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | TAS |
R-HSA-69473 | G2/M DNA damage checkpoint | TAS |
R-HSA-69481 | G2/M Checkpoints | TAS |
R-HSA-69620 | Cell Cycle Checkpoints | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-73894 | DNA Repair | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
R-HSA-8953897 | Cellular responses to external stimuli | TAS |
R-HSA-912446 | Meiotic recombination | IEA |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
18638378 | Analysis of variants in DNA damage signalling genes in bladder cancer. (2008 Jul 18) | Choudhury A | BMC Med Genet |
28476809 | Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer. (2017 May) | Chuang CL | Anticancer Res |
28729482 | BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity. (2017 Oct) | Tacconi EM | EMBO Mol Med |